Edition:
United Kingdom

Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

51.58USD
4:18pm BST
Change (% chg)

$0.16 (+0.31%)
Prev Close
$51.42
Open
$52.39
Day's High
$53.25
Day's Low
$51.58
Volume
28,224
Avg. Vol
169,539
52-wk High
$99.77
52-wk Low
$41.63

About

Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. The Company's cancer product candidates are... (more)

Overall

Beta: 2.27
Market Cap(Mil.): $3,018.94
Shares Outstanding(Mil.): 58.71
Dividend: --
Yield (%): --

Financials

  AGIO.OQ Industry Sector
P/E (TTM): -- 106.73 37.60
EPS (TTM): -5.99 -- --
ROI: -40.81 7.77 12.15
ROE: -46.88 8.30 17.02

Earnings vs. Estimates